IBO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Impact Biomedical Inc (IBO) is not a good buy for a beginner, long-term investor with $50,000-$100,000 to invest. The technical indicators are bearish, the financial performance is weak, and there are no positive catalysts or trading signals to support a buy decision.
The MACD is negative and expanding downward, RSI is neutral at 41.25, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.445 and resistance at 0.637. Overall, the technical trend is bearish.
NULL. No recent news, no trading signals, and no significant insider or hedge fund activity.
Weak financial performance in 2025/Q3 with a YoY net income drop of -134.61%, EPS decline of -300%, and a negative gross margin. Additionally, no recent congress trading data or influential figure activity supports the stock.
In 2025/Q3, revenue was flat YoY at 18,000. Net income dropped significantly to -1,470,000 (-134.61% YoY), and EPS fell to -0.12 (-300% YoY). Gross margin remains negative at -1505.56%.
No analyst rating or price target data available.
